Home
Therapeutic Categories
- BACK
- Therapeutic Categories
- Allergy & Immunology
  - BACK
  - Allergy & Immunology
  - Chronic Spontaneous Urticaria
  - Food Allergies
  - Pediatric Food Allergies
  - Search for:
- Dermatology
  - BACK
  - Dermatology
  - Atopic Dermatitis
  - Plaque Psoriasis
  - Search for:
- Endocrinology
  - BACK
  - Endocrinology
  - Type 2 Diabetes
  - Search for:
- Gastroenterology
  - BACK
  - Gastroenterology
  - Crohn's Disease
  - Ulcerative Colitis
  - Search for:
- Hematology
  - BACK
  - Hematology
  - Chronic Immune Thrombocytopenia
  - Paroxysmal Nocturnal Hemoglobinuria
  - Sickle Cell Disease
  - Search for:
- Hepatology
  - BACK
  - Hepatology
  - Liver Fibrosis
  - Search for:
- Infectious Diseases
  - BACK
  - Infectious Diseases
  - Adolescent Vaccinations
  - COVID-19 Prevention
  - Influenza
  - Search for:
- Nephrology
  - BACK
  - Nephrology
  - IgAN
  - IgAN & C3G
  - Renal Transplant Maintenance
  - Search for:
- Neurology
- Oncology
- Ophthalmology
  - BACK
  - Ophthalmology
  - Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
  - Wet AMD
  - Search for:
- Osteoporosis
  - BACK
  - Osteoporosis
  - Osteoporosis
  - Search for:
- Psychiatry
  - BACK
  - Psychiatry
  - Major Depressive Disorder
  - Schizophrenia
  - Tardive Dyskinesia
  - Search for:
- Pulmonology
  - BACK
  - Pulmonology
  - Asthma
  - COPD
  - Interstitial Lung Disease
  - Search for:
- Rheumatology
  - BACK
  - Rheumatology
  - Psoriatic Arthritis
  - Rheumatoid Arthritis
  - Systemic Lupus Erythematosus
  - Search for:
- Urology
  - BACK
  - Urology
  - Uncomplicated Urinary Tract Infections
  - Search for:
- Search for:
Conference Reporter
Expert Directory
About Expert Perspectives
Login/Register
Search for:

clinical topic updates

Research on Pulmonary Hypertension–Specific Therapeutics for Patients With Chronic Lung Disease

Research on Pulmonary Hypertension–Specific Therapeutics for Patients With Chronic Lung Disease

clinical topic updates
By Steven D. Nathan, MD

Clarified Hemodynamic Definitions of WHO Group 3 Pulmonary Hypertension

Clarified Hemodynamic Definitions of WHO Group 3 Pulmonary Hypertension

clinical topic updates
By Steven D. Nathan, MD

MEK Inhibition and Targeted Combinations for Advanced Lung Cancer

MEK Inhibition and Targeted Combinations for Advanced Lung Cancer

clinical topic updates
By Roy S. Herbst, MD, PhD

Real-World Data on Mantle Cell Lymphoma and Its Treatment

Real-World Data on Mantle Cell Lymphoma and Its Treatment

clinical topic updates
By John P. Leonard, MD

First and Second Generations of Bruton Tyrosine Kinase Inhibitors in the Treatment of Mantle Cell Lymphoma

First and Second Generations of Bruton Tyrosine Kinase Inhibitors in the Treatment of Mantle Cell Lymphoma

clinical topic updates
By Anita Kumar, MD

Load More

2026 Expert Perspectives®

Privacy Policy Terms of Service About Expert Perspectives

Your California Privacy Rights Do Not Sell My Personal Information

Login Expert Perspectives

Forgot Password?

or Create an Account

Create an Account

Forgot Password?